| Authors | Title | Published Date | Journal | HTML Citation Link |
|---|---|---|---|---|
| Mulliken JS, Langelier C, Budak JZ, Miller S, Dynerman D, Hao S, Li LM, Crawford E, Lyden A, Woodworth MH, DeRisi JL, Desmond E, Browne C, Luu A, Grandis DJ, Grossman W, Deuse T, Melcher GP | Bergeyella cardium: Clinical Characteristics and Draft Genome of an Emerging Pathogen in Native and Prosthetic Valve Endocarditis | 2019-03-15 | Open Forum Infect Dis | Open Forum Infect Dis. 2019 Mar 15;6(4):ofz134. doi: 10.1093/ofid/ofz134. |
| Turner N, Strand A, Grewal D, Cox G, Arif S, Baker AW, Maziarz EK, Saullo JH, Wolfe CR. | Use of Letermovir as Salvage Therapy for Drug-resistant CMV: A Case Series | 2019-03-01 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02337-18. doi: 10.1128/AAC.02337-18. Print 2019 Mar |
| Holland TL, Chambers HF, Boucher HW, Corey GR, Coleman R, Castaneda-Ruiz B, Fowler VG Jr | Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults | 2019-02-15 | Clin Infect Dis | Clin Infect Dis. 2019 Feb 15;68(5):865-872. doi: 10.1093/cid/ciy774 |
| Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheelter M, Tolomeo P, Han JH | The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study | 2019-02-14 | BMC Infect Dis | BMC Infect Dis. 2019 Feb 14;19(1):163. doi: 10.1186/s12879-019-3804-y |
| Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer M | Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience | 2019-02-01 | Am J Transplant | Am J Transplant. 2018 Aug 7. doi: 10.1111/ajt.15058. [Epub ahead of print] |
| Jacobs MR, Abdelhamed AM, Good CE, Rhoads DD, Hujer KM, Hujer AM, Domitrovic TN, Rudin SD, Fouts DE, Richter SS, van Duin D, Kreiswirth BN, Bonomo RA | ARGONAUT-I: Activity of cefiderocol (S-649266), a siderophore cephalosporin, against Gram negative bacteria including carbapenem resistant nonfermenters and Enterobacteriaceae with defined extended-spectrum ?-lactamases and carbapenemases | 2018-12-21 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01801-18. doi: 10.1128/AAC.01801-18. Print 2019 Jan. |
| Luterbach CL, Boshe A, Henderson H, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, van Duin D | The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae | 2018-12-14 | Open Forum Infect Dis | Open Forum Infect Dis. 2018 Dec 14;6(1):ofy351. doi: 10.1093/ofid/ofy351. eCollection 2019 Jan. |
| Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheeler MK, Tolomeo P, Han JH; CDC Prevention Epicenters Program. | Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae | 2018-12-01 | Infect Control Hosp Epidemiol | Infect Control Hosp Epidemiol. 2018 Dec;39(12):1431-1435. doi: 10.1017/ice.2018.254. Epub 2018 Oct 30. |
| Evans S, Rubin DB, Powers JH, Follmann. | Analysis Populations in Anti-Infective Clinical Trials: Whom to Analyze? | 2018-12-01 | Stat Commun Infect Dis | Stat Commun Infect Dis. 2018 Dec;10(1). pii: 20170002. doi: 10.1515/scid-2017-0002. Epub 2018 Aug 29 |
| van Duin D, Gu P, Dong J, Pfaff M, Arias RM, Evans B, Yu Y, Li L, Zhang F, Liu Z, Cao B, Fowler VG, Wang M | China-United States Research Collaborations in Antimicrobial Resistance | 2018-11-14 | Clin Infect Dis | Clin Infect Dis. 2018 Nov 13;67(suppl_2):S142-S145. doi: 10.1093/cid/ciy694. |
| Golpisamy SN, Woodworth MH,Wang T, Carpentieri C, Friedman-Moraco R, Mehta A, Larsen C, Kraft C | The use of microbiome restoration therapeutics to eliminate intestinal colonization with multi-drug resistant organisms | 2018-11-01 | Am J Med Sci | Am J Med Sci. 2018 Nov;356(5):433-440. doi: 10.1016/j.amjms.2018.08.015. Epub 2018 Aug 29. |
| Patel R, Fang FC | Diagnostic Stewardship: Opportunity for a Laboratory-Infectious Diseases Partnership | 2018-08-16 | Clin Infect Dis | Clin Infect Dis. 2018 Aug 16;67(5):799-801. doi: 10.1093/cid/ciy077. |
| Wenzler E, Bleasdale SC, Sikka M, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA; Antibacterial Resistance Leadership Group. | Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants (PROOF) | 2018-07-27 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00464-18. doi: 10.1128/AAC.00464-18. Print 2018 Aug. |
| Kebriaei R, Rice SA, Singh KV, Stamper KC, Dinh AQ, Rios R, Diaz L, Murray BE, Munita JM, Tran TT, Arias CA, Rybak MJ | Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with ?-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions | 2018-07-27 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00315-18. doi: 10.1128/AAC.00315-18. Print 2018 Aug. |
| Tamma PD, Pierce VM, Cosgrove SE, Lautenbach E, Harris AD, Rayapati D, Han JH | Can the Ceftriaxone Breakpoints be Increased without Compromising Patient Outcomes? | 2018-06-08 | Open Forum Infect Dis | Open Forum Infect Dis. 2018 Jun 8;5(6):ofy139. doi: 10.1093/ofid/ofy139. eCollection 2018 Jun. |
| Miller WR, Seas C, Carvajal LP, Diaz L, Echeverri AM, Ferro C, Rios R, Porras P, Luna C, Gotuzzo E, Munita JM, Nannini E, Carcamo C, Reyes J, Arias CA | The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia | 2018-05-23 | Open Forum Infect Dis | Open Forum Infect Dis. 2018 May 23;5(6):ofy123. doi: 10.1093/ofid/ofy123. eCollection 2018 Jun 1. |
| Mamo Y, Woodworth MH, Wang T, Dhere T, Kraft CS | Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection | 2018-05-17 | Clin Infect Dis | Clin Infect Dis. 2018 May 17;66(11):1705-1711. doi: 10.1093/cid/cix1097. |
| Robinson ML, Kadam D, Kagal A, Khadse S, Kinikar A, Valvi C, Basavaraj A, Bharadwaj R, Marbaniang I, Kanade S, Raichur P, Sachs J, Klein E, Cosgrove S, Gupta A, Mave V | Antibiotic Utilization and the Role of Suspected and Diagnosed Mosquito-borne Illness Among Adults and Children With Acute Febrile Illness in Pune, India | 2018-05-02 | Clin Infect Dis | Clin Infect Dis. 2018 May 2;66(10):1602-1609. doi: 10.1093/cid/cix1059. |
| Richter SS, Karichu J, Otiso J, Van Heule H, Keller G, Cober E, Rojas LJ, Hujer AM, Hujer KM, Marshall S, Perez F, Rudin SD, Domitrovic TN, Kaye KS, Salata R, van Duin D, Bonomo RA | Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins | 2018-05-01 | Diagn Microbiol Infect Dis | Diagn Microbiol Infect Dis. 2018 May;91(1):89-92. |
| Gopalsamy SN, Sherman A, Woodworth MH, Lutgring JD, Kraft CS | Fecal Microbiota Transplant for Multidrug-Resistant Organism Decolonization Administered During Septic Shock | 2018-04-01 | Infect Control Hosp Epidemiol | Infect Control Hosp Epidemiol. 2018 Apr;39(4):490-492. doi: 10.1017/ice.2017.300. Epub 2018 Jan 18. |
| Kanwar A, Marshall SH, Perez F, Tomas M, Jacobs MR, Hujer AM, Domitrovic TN, Rudin SD, Rojas LJ, Kreiswirth BN, Chen L, Quinones-Mateu M, van Duin D, Bonomo RA; Antibacterial Resistance Leadership Group | Emergence of Resistance to Colistin During the Treatment of Bloodstream Infection Caused by Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae | 2018-04-01 | Open Forum Infect Dis | Open Forum Infect Dis. 2018 Apr 23;5(4):ofy054. doi: 10.1093/ofid/ofy054. eCollection 2018 Apr. |
| Huskins WC, Fowler VG Jr, Evans S | Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research | 2018-03-19 | Clin Infect Dis | Clin Infect Dis. 2018 Mar 19;66(7):1140-1146. doi: 10.1093/cid/cix907. |
| Wang T, Kraft CS, Woodworth MH, Dhere T, Eaton ME | Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections | 2018-02-01 | Open Forum Infect Dis | Open Forum Infect Dis. 2018 Jan 15;5(2):ofy016. doi: 10.1093/ofid/ofy016. eCollection 2018 Feb. Open Forum Infect Dis. 2018 Jan 15;5(2):ofy016. doi: 10.1093/ofid/ofy016. eCollection 2018 Feb. |
| El Chakhtoura NG, Saade E, Iovleva A, Yasmin M, Wilson B, Perez F, Bonomo RA | Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy | 2018-02-01 | Expert Rev Anti Infect Ther | Expert Rev Anti Infect Ther. 2018 Feb;16(2):89-110. doi: 10.1080/14787210.2018.1425139. Epub 2018 Jan 16. |
| Hamasaki T, Evans SR, Asakura K | Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review | 2018-01-31 | J Biopharm Stat | J Biopharm Stat. 2018;28(1):28-51. doi: 10.1080/10543406.2017.1378668. Epub 2017 Oct 30. |
| Tsalik EL, Bonomo RA, Fowler VG | New Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance | 2018-01-29 | Annu Rev Med | Annu Rev Med. 2018 Jan 29;69:379-394. doi: 10.1146/annurev-med-052716-030320. |
| Van Duin D, Lok J, Earley M, Cober E, Richter S, Perez F, Salata R, Kalayjian R, Watkins R, Doi Y, Kaye K, Fowler V Jr, Paterson D, Bonomo R, Evans S | Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae | 2018-01-06 | Clin Infect Dis | Clin Infect Dis. 2018 Jan 6;66(2):163-171. doi: 10.1093/cid/cix783. |
| Chotiprasitsakul D, Han JH, Cosgrove SE, Harris AD, Lautenbach E, Conley AT, Tolomeo P, Wise J, & Tamma PD for the Antibacterial Resistance Leadership Group | Comparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course versus Prolonged-Course Antibiotic Therapy in a Propensity-Score Matched Multicenter Cohort | 2018-01-06 | Clin Infect Dis | Clin Infect Dis. 2018 Jan 6;66(2):172-177. doi: 10.1093/cid/cix767. |
| Eilertson B, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, DeHovitz J, Kreiswirth B, van Duin D, for the ARLG | Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy | 2017-10-06 | Open Forum Infect Dis | Open Forum Infect Dis. 2017 Oct 6;4(4):ofx216. doi: 10.1093/ofid/ofx216. eCollection 2017 Fall. |
| Nielsen TB, Pantapalangkoor P, Yan J, Luna BM, Dekitani K, Bruhn K, Tan B, Junus J, Bonomo RA, Schmidt AM, Everson M, Duncanson F, Doherty TM, Lin L, Spellberg B | Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE | 2017-08-22 | mBio | MBio. 2017 Aug 22;8(4). pii: e00818-17. |
| Henig O, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Evans S, Fowler VG, Bonomo RA, van Duin D, Kaye KS, for the Antibacterial Resistance Leadership Group | A Prospective Observational Study of the Epidemiology, Management and Outcomes of Skin and Soft Tissue Infections due to Carbapenem-Resistant Enterobacteriaceae | 2017-07-27 | Open Forum Infect Dis | Open Forum Infect Dis 2017;4(3):ofx157. https://doi.org/10.1093/ofid/ofx157 |
| Thom KA, Rock C, Jackson SS, Johnson JK, Srinivasan A, Magder LS, Roghmann MC, Bonomo RA, Harris AD | Factors Leading to Transmission Risk of Acinetobacter baumannii | 2017-07-01 | Crit Care Med | Crit Care Med. 2017 Jul;45(7):e633-e639. doi: 10.1097/CCM.0000000000002318. |
| Asakura K, Hamasaki T, Evans SR | Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpoints | 2017-07-01 | Biom J | Biom J. 2017 Jul;59(4):703-731. doi: 10.1002/bimj.201600026. Epub 2016 Oct 19. |
| Rojas LJ, Hujer AM, Rudin SD, Wright MS, Domitrovic TN, Marshall SH, Hujer KM, Richter SS, Cober E, Perez F, Adams MD, van Duin D, Bonomo RA | NDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas. | 2017-06-27 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00454-17. doi: 10.1128/AAC.00454-17. Print 2017 Jul. |
| Shin WS, Bergstrom A, Bonomo RA, Crowder MW, Muthyala R, Sham YY | Discovery of 1-Hydroxypyridine-2(1H)-thione-6-carboxylic Acid as aFirst-in-Class Low-Cytotoxic Nanomolar Metallo beta-Lactamase Inhibitor | 2017-06-07 | ChemMedChem | ChemMedChem. 2017 Jun 7;12(11):845-849. doi: 10.1002/cmdc.201700182. Epub 2017 May 22. |
| Evans SR, Hujer AM, Jiang H, Hill CB, Hujer KM, Mediavilla JR, Manca C, Tran TTT, Domitrovic TN, Higgins PG, Seifert H, Kreiswirth BN, Patel R, Jacobs MR, Chen L, Sampath R, Hall T, Marzan C, Fowler VG Jr, Chambers HF, Bonomo RA | Correction for Evans et al., "Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III" | 2017-06-01 | J Clin Microbiol | J Clin Microbiol. 2017 Jun;55(6):1970. doi: 10.1128/JCM.00525-17. |
| Thaden JT, Park LP, Maskarinec SA, Ruffin F, Fowler VG, Van Duin D | Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria | 2017-05-24 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02671-16. |
| Evans SR, Harris AD | Methods and Issues in Studies of CRE | 2017-05-19 | Virulence | Virulence. 2017 May 19;8(4):453-459. doi: 10.1080/21505594.2016.1213473. Epub 2016 Jul 28. |
| Sugimoto T, Hamasaki T, Evans SR, Sozu T | Sizing clinical trials when comparing bivariate time-to-event outcomes | 2017-04-30 | Stat Med | Stat Med. 2017 Apr 30;36(9):1363-1382. |
| Ochiai T, Hamasaki T, Evans SR, Asakura K, Ohno Y | Group-Sequential Three-Armnoninferiority Clinical Trial Designs | 2017-04-17 | J Biopharm Stat | J Biopharm Stat. 2016 Feb 18:1-25. |
| Marshall S, Hujer AM, Rojas LJ, Papp-Wallace KM, Humphries RM, Spellberg B, Hujer KM, Marshall EK, Rudin SD, Perez F, Wilson BM, Wasserman RB, Chikowski L, Paterson DL, Vila AJ, van Duin D, Kreiswirth BN, Chambers HF, Fowler VG Jr, Jacobs MR, Pulse ME, Weiss WJ, Bonomo RA | Can Ceftazidime-Avibactam and Aztreonam Overcome Beta-Lactam Resistance Conferred by Metallo-beta-Lactamases in Enterobacteriaceae? | 2017-03-24 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02243-16. |
| Rojas LJ, Salim M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Kaye KS, Evans SE, Fowler VG, Bonomo RA, van Duin D | Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality | 2017-03-15 | Clin Infect Dis | Clin Infect Dis. 2017 Mar 15;64(6):711-718. doi: 10.1093/cid/ciw805. |
| Murray B, Jezek A | CID Supplement: The Antibacterial Resistance Leadership Group: The First Steps | 2017-03-15 | Clin Infect Dis | Clin Infect Dis. 2017 Mar 15;64(suppl_1):S1-S2. doi: 10.1093/cid/ciw823. |
| Chambers HF, Cross HR, Evans SR, Kreiswirth BN, Fowler VG, and the ARLG | CID Supplement: The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress | 2017-03-15 | Clin Infect Dis | Clin Infect Dis. 2017 Mar 15;64(suppl_1):S3-S7. doi: 10.1093/cid/ciw824. |
| Cross HR, Harris A, Arias RK, Chambers HF, Fowler VG, and the LOC of the ARLG | CID Supplement: Transforming Concepts into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group | 2017-03-15 | Clin Infect Dis | Clin Infect Dis. 2017 Mar 15;64(suppl_1):S8-S12. doi: 10.1093/cid/ciw825. |
| Manca C, Hill C, Hujer AM, Patel R, Evans SR, Bonomo RA, Kreiswirth BN, and the LC of the ARLG | CID Supplement: Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group | 2017-03-15 | Clin Infect Dis | Clin Infect Dis. 2017 Mar 15;64(suppl_1):S13-S17. doi: 10.1093/cid/ciw826. |
| Huvane J, Komarow L, Hill C, Tran T, Pereira C, Rosenkranz SL, Finnemeyer M, Earley M, Jiang J, Wangt R, Lok J, Evans SR, and the SDMC of the ARLG | CID Supplement: Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group | 2017-03-15 | Clin Infect Dis | Clin Infect Dis. 2017 Mar 15;64(suppl_1):S18-S23. doi: 10.1093/cid/ciw827. |
| Doernberg SB, Lodise TP, Thaden JT, Munita J, Cosgrove S, Arias C, Boucher H, Corey GR, Lowy F, Murray B, Miller LG, Holland, and the Gram-Positive Committee of the ARLG | CID Supplement: Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group | 2017-03-15 | Clin Infect Dis | Clin Infect Dis. 2017 Mar 15;64(suppl_1):S24-S29. doi: 10.1093/cid/ciw828. |
| Doi Y, Bonomo RA, Hooper DC, Kaye KS, Johnson JR, Clancy CJ, Thaden JT, Stryjewski ME, van Duin D, and the Gram-Negative Committee of the ARLG | CID Supplement: Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group | 2017-03-15 | Clin Infect Dis | Clin Infect Dis. 2017 Mar 15;64(suppl_1):S30-S35. doi: 10.1093/cid/ciw829. |
| Anderson DJ, Jenkins T, Evans S, Harris A, Weinstein R, Tamma P, Han J, Banarjee R, Patel R, Zaoutis T, Lautenbach E, and the Stewardship and Infection Control Committee of the ARLG | CID Supplement: The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group | 2017-03-15 | Clin Infect Dis | Clin Infect Dis. 2017 Mar 15;64(suppl_1):S36-S40. doi: 10.1093/cid/ciw830. |
| Tsalik EL, Petzold E, Kreiswirth BN, Bonomo RA, Banerjee R, Lautenbach E, Evans SR, Hanson KE, Patel R, and the Diagnostics and Devices Committee of the ARLG | CID Supplement: Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group | 2017-03-15 | Clin Infect Dis | Clin Infect Dis. 2017 Mar 15;64(suppl_1):S41-S47. doi: 10.1093/cid/ciw831. |
| Evans SR, Powers J | Evaluating Anti-Infective Drugs in the Resistant Pathogen Setting: Can we Use External Controls? | 2017-03-14 | Stat Commun Infect Dis | Stat Commun Infect Dis. 2017;9(1). pii: 20160003. |
| Haidar G, Clancy CJ, Shields RK, Hao B, Cheng S, Nguyen MH | Mutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum ?-Lactamases | 2017-02-23 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02097-16. |
| Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJ | Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections | 2017-02-23 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02097-16. |
| Patel R, Tsalik EL, Petzold E, Fowler VG, Klausner JD, Evans S, and the Antibaceterial Resistance Leadership Group | MASTERMIND Bringing Microbial Diagnostics to the Clinic | 2017-02-01 | Clin Infect Dis | Clin Infect Dis. 2017 Feb 1;64(3):355-360. doi: 10.1093/cid/ciw788. Epub 2016 Dec 7. |
| Viau RA, Kiedrowski LM, Kreiswirth BN, Adams M, Perez F, Marchaim D, Guerrero DM, Kaye KS, Logan LK, Villegas MV, Bonomo RA | A Comparison of Molecular Typing Methods Applied to Enterobacter cloacae complex: hsp60 Sequencing, Rep-PCR, and MLST | 2017-02-01 | Pathog Immun | Pathog Immun. 2017;2(1):23-33. doi: 10.20411/pai.v2i1.99. Epub 2017 Feb 1. |
| Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B | Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges | 2017-01-01 | Clin Microbiol Rev | Clin Microbiol Rev. 2017 Jan;30(1):409-447. |
| Evans SR, Hujer AM, Jiang H, Hill CB, Hujer KM, Mediavilla JR, Manca C, Tran TT, Domitrovic TN, Higgins PG, Kreiswirth BN, Patel R, Jacobs MR, Chen L, Sampath R, Hall T, Marzan C, Fowler V, Chambers H, Bonomo RA, and the Antibacterial Resistance Leadership Group | Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics (RMDs) to Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. PRIMERS III | 2016-12-28 | J Clin Microbiol | J Clin Microbiol. 2016 Dec 28;55(1):134-144. doi: 10.1128/JCM.01524-16. Print 2017 Jan. |
| Spellberg B, Bonomo RA | Editorial Commentary: Ceftazidime-Avibactam and Carbapenem-Resistant Enterobacteriaceae: ''We're Gonna Need a Bigger Boat'' | 2016-12-15 | Clin Infect Dis | Clin Infect Dis. 2016 Dec 15;63(12):1619-1621. Epub 2016 Sep 13. |
| Evans, SR, Follmann | Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step Toward Pragmatism in Benefit:Risk Evaluation | 2016-12-06 | Stat Biopharm Res | Stat Biopharm Res 2016;8(4):386-393. |
| Pennello G, Pantoja-Galicia N, Evans S | Comparing diagnostic tests on benefit-risk | 2016-12-01 | J Biopharm Stat | J Biopharm Stat. 2016;26(6):1083-1097. Epub 2016 Aug 22. |
| Banerjee R, Ozenci V, Patel R | Individualized Approaches Are Needed for Optimized Blood Cultures | 2016-11-15 | Clin Infect Dis | Clin Infect Dis. 2016 Nov 15;63(10):1332-1339. Epub 2016 Aug 23. |
| Spellberg B, Bartlett JG, Gilbert DN | How to Pitch an Antibiotic Stewardship Program to the Hospital C-Suite | 2016-10-15 | Open Forum Infect Dis | Open Forum Infect Dis. 2016 Oct 15;3(4):ofw210. eCollection 2016 Oct. |
| Patel R | New Developments in Clinical Bacteriology Laboratories | 2016-10-01 | Mayo Clin Proc | Mayo Clin Proc. 2016 Oct;91(10):1448-1459. doi: 10.1016/j.mayocp.2016.06.020. Epub 2016 Aug 21. |
| Goodman KE, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Massey CJ, Tamma PD; Antibacterial Resistance Leadership Group. | A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum ?-Lactamase-Producing Organism | 2016-10-01 | Clin Infect Dis | Clin Infect Dis. 2016 Oct 1;63(7):896-903. |
| Mills JP, Wilck MB, Weikert BC, Porrett PM, Timko D, Alby K, Bonomo RA, Blumberg EA | Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen | 2016-10-01 | Transpl Infect Dis | Transpl Infect Dis. 2016 Oct;18(5):777-781. |
| Evans S, Pennello G, Pantoja-Galicia N, Jiang H, Hujer AM, Hujer KM, Manca C, Hill C, Jacobs MR, Chen L, Patel R, Kreiswirth BN, Bonomo RA, and the Antibacterial Resistance Leadership Group (ARLG) | Benefit-Risk Evaluation for Diagnostics: a Framework (BED-FRAME) | 2016-09-15 | Clin Infect Dis | Clin Infect Dis. 2016 Sep 15;63(6):812-7. |
| Spellberg B | The New Antibiotic Mantra-''Shorter Is Better'' | 2016-09-01 | JAMA Intern Med | JAMA Intern Med. 2016 Sep 1; 176(9): 12541255. |
| van Duin D, Bonomo RA | Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation Beta-Lactam/Beta-Lactamase Inhibitor Combinations | 2016-07-15 | Clin Infect Dis | Clin Infect Dis. 2016 Jul 15;63(2):234-41. |
| Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S, Fowler Jr VG, Bonomo RA, van Duin D, for the Antibacterial Resistance Leadership Group | Spectrum of Excess Mortality due to Carbapenem-Resistant Klebsiella pneumoniae Infections | 2016-06-30 | Clin Microbiol Infect | Clin Microbiol Infect. 2016 Jun;22(6):513-9. |
| Perez F, El Chakhtoura NG, Papp-Wallace KM, Wilson BM, Bonomo RA | Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy? | 2016-04-01 | Expert Opin Pharmacother | Expert Opin Pharmacother. 2016 Apr;17(6):761-81. |
| Messina JA, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Kaye KS, Evans S, Bonomo RA, Fowler Jr VG, van Duin D | Hospital Readmissions in Patients with Carbapenem-Resistant Klebsiella 1 pneumoniae | 2016-03-31 | Infect Control Hosp Epidemiol | Infect Control Hosp Epidemiol. 2015 Dec 21:1-8. [Epub ahead of print] |
| Evans S, Follmann D, Schoenfeld D, Fowler VG Jr, Chambers HF | Reply to Phillips, Morris, and Walker | 2016-03-15 | Clin Infect Dis | Clin Infect Dis. 2016 Mar 15;62(6):815-6. |
| Wright MS, Iovleva A, Jacobs MR, Bonomo RA, Adams MD | Genome Dynamics of Multidrug-resistant Acinetobacter baumannii during Infection and Treatment | 2016-03-03 | Genome Med | Genome Med. 2016 Mar 3;8(1):26. doi: 10.1186/s13073-016-0279-y. |
| Thaden JT, Keller AE, Shire NJ, Camara MM, Otterson L, Huband M, Guenther CM, Zhao W, Warrener P, Stover KC, Foslwer VG, DiGiandomenico A | Pseudomonas aeruginosa Bacteremic Patients Exhibit Non-Protective Antibody Titers against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide | 2016-02-15 | J Infect Dis | J Infect Dis. 2016 Feb 15;213(4):640-8 |
| Tsalik EL, Henao R, Nichols M, Burke T, Ko ER, McClain MT, Hudson LL, Mazur A, Freeman DH, Veldman T, Langley RJ, Quackenbush EB, Glickman SW, Cairns CB, Jaehne AK, Rivers EP, Otero RM, Zaas AK, Kingsmore SF, Lucas J, Fowler VG, Carin L, Ginsburg GS, Woods CW | Host Gene Expression Classifiers Diagnose Acute Respiratory Illness Etiology | 2016-01-20 | Sci Transl Med | Sci Transl Med. 2016 Jan 20;8(322):322ra11. |
| Evans S, Hujer AM, Jiang H, Hujer KM, Hall T, Marzan C, Jacobs MR, Sampath R, Ecker DJ, Manca C, Chavda K, Zhang P, Fernandez H, Chen L, Mediavilla J, Hill C, Perez F, Caliendo A, Fowler V, Chambers H, Kreiswirth B, Bonomo RA, and the Antimicrobial Resistance Leadership Group | Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II | 2016-01-15 | Clin Infect Dis | Clin Infect Dis. 2016 Jan 15;62(2):181-9 |
| Messina JA, Thaden JT, Sharma-Kuinkel BK, Fowler VG | Impact of Bacterial and Human Genetic Variation on Staphylococcus aureus Infections | 2016-01-14 | PLoS Pathogens | PLoS Pathog. 2016 Jan 14;12(1):e1005330. |
| Evans SR, Follmann D | Fundamentals and Innovation in Antibiotic Trials | 2015-12-17 | Stat Biopharm Res | Stat Biopharm Res. 2015;7(4):331-336. |
| Spellberg B, Doi Y | The Rise of Fluoroquinolone-Resistant Escherichia coli in the Community: Scarier Than We Thought | 2015-12-15 | J Infect Dis | J Infect Dis. 2015 Dec 15;212(12):1853-5. |
| Ericson JE, Popoola VO, Smith PB, Benjamin DK, Fowler VG, Benjamin DK Jr, Clark RH, Milstone AM | Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants | 2015-12-01 | JAMA Pediatr | JAMA Pediatr. 2015;169(12):1105-1111 |
| Thaden JT, Ericson JE, Cross H, Bergin S, Messina JA, Fowler VG Jr, Benjamin DK Jr, Clark RH, Hornik CP, Smith PB | Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants | 2015-10-30 | Pediatr Infect Dis J | Pediatr Infect Dis J. 2015 Nov;34(11):1175-9. |
| Banerjee R,Teng C, Cunningham S, Ihde S, Steckelberg J, Moriarty JP, Shah ND, Mandrekar J, Patel R | Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing | 2015-10-01 | Clin Infect Dis | Clin Infect Dis. 2015 Oct 1;61(7):1071-80. doi: 10.1093/cid/civ447. Epub 2015 Jul 20. |
| Choe H, Narayanan AS, Gandhi DA, Weinberg A, Marcus RE, Lee Z, Bonomo RA, Greenfield EM | Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration | 2015-09-30 | Clin Orthop Relat Res | Clin Orthop Relat Res. 2015 Sep;473(9):2898-907. |
| Khatri A, Naeger Murphy N, Wiest P, Osborn M, Garber K, Hecker M, Hurless K, Rudin SD, Jacobs MR, Kalayjian RC, Salata RA, van Duin D, Perez F, Bonomo RA, Paterson DL, Harris PN | Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae | 2015-08-31 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2015 Aug;59(8):4375-8. doi: 10.1128/AAC.00553-15. |
| Bergin SP, Thaden J, Ericson JE, Cross H, Messina J, Clark RH, Fowler V, Benjamin DK, Hornik CP, Smith PB | Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy | 2015-08-31 | Pediatr Infect Dis J | Pediatr Infect Dis J. 2015;34(9):933-936. |
| Evans SR, Rubin D, Follman D, Penello G, Huskins WC, Powers J, Schoenfeld D, Chuang-Stein C, Fowler V, Lautenbach E, Chambers HF | Desirability of Outcome Ranking (DOOR) and Response Adjusted for Days of Antibiotic Risk (RADAR) | 2015-08-26 | Clin Infect Dis | Clin Infect Dis. 2015 Sep 1;61(5):800-6. |
| van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RA, Kaye KS | Residence in Skilled Nursing Facilities is associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae | 2015-08-26 | Infect Control Hosp Epidemiol | Infect Control Hosp Epidemiol. 2015 Aug;36(8):942-8 |
| Uno H, Wittes J, Fu H, Solomon SD, Claggett B, Tian L, Cai T, Pfeffer MA, Evans SR, Wei LJ | Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies | 2015-07-21 | Ann Intern Med | Ann Intern Med. 2015 Jul 21;163(2):127-34. |
| Ando Y, Hamasaki T, Evans SR, Asakura K, Sugimoto T, Sozu T, Ohno Y | Sample size considerations in clinical trials when comparing two interventions using multiple co-primary binary relative risk contrasts | 2015-06-24 | Stat Biopharm Res | Stat Biopharm Res. 2015 Jun 24;7(2):81-94. |
| Messina JA, Fowler VG Jr, Corey GR | Oritavancin for Acute Bacterial Skin and Skin Structure Infections | 2015-05-17 | Expert Opin Pharmacother | Expert Opin Pharmacother. 2015 May;16(7):1091-8. |
| Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE; for the Antibacterial Resistance Leadership Group | Carbapenem Therapy is Associated with Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum ?-Lactamase Bacteremia | 2015-05-01 | Clin Infect Dis | Clin Infect Dis. 2015 May 1;60(9):1319-25. doi: 10.1093/cid/civ003. Epub 2015 Jan 13. |
| Hamasaki T, Asakura K, Evans SR, Sugimoto T, Suzo T | Group-sequential Strategies in Clinical Trials with Multiple Co-primary Outcomes | 2015-04-14 | Stat Biopharm Res | Stat Biopharm Res. 2015;7(1):36-54. |
| van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Kaye KS, Bonomo RA | Impact of Therapy and Strain Type on Outcomes in Urinary Tract Infections Caused by Carbapenem-Resistant Klebsiella Pneumoniae | 2015-04-01 | J Antimicrob Chemother | J Antimicrob Chemother. 2015 Apr;70(4):1203-11 |
| Tugal D, Lynch M, Hujer AM, Rudin S, Perez F, Bonomo RA | Multi-Drug-Resistant Klebsiella pneumoniae Pancreatitis: A New Challenge in a Serious Surgical Infection | 2015-04-01 | Surg Infect (Larchmt) | Surg Infect (Larchmt). 2015 Apr;16(2):188-93. |
| Ericson JE, Thaden J, Cross H, Clark RH, Fowler V, Benjamin DK Jr, Cohen-Wolkowiez M, Hornik CP, Smith PB | No Survival Benefit with Empirical Vancomycin Therapy for Coagulase-negative Staphylococcal Bloodstream Infections in Infants | 2015-03-17 | Pediatr Infect Dis J | Pediatr Infect Dis J. 2015 Apr;34(4):371-5. |
| Spellberg B, Barlett J, Wunderink R, Gilbert DN | Novel Approaches Are Needed to Develop Tomorrows Antibacterial Therapies | 2015-01-15 | Am J Respir Crit Care Med | Am J Respir Crit Care Med. 2015 Jan 15;191(2):135-40. |
| Wright MS, Suzuki Y, Jones MB, Marshall SH, Rudin SD, van Duin D, Kaye K, Jacobs M, Bonomo RA, Adams MD | Genomic and Transcriptomic Analyses of Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae Reveal Independent Pathways of Resistance | 2015-01-01 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2015 Jan;59(1):536-43. doi: 10.1128/AAC.04037-14. Epub 2014 Nov 10. |
| van Duin D, Cober E, Richter SS, Perez F, Cline M, Kaye KS, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RA | Tigecycline Therapy for Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Bacteriuria Leads to Tigecycline Resistance | 2014-12-01 | Clin Microbiol Infect | Clin Microbiol Infect. 2014 Dec;20(12):O1117-20. doi: 10.1111/1469-0691.12714. Epub 2014 Dec 12. |
| Vazquez Melendez EL, Farrell JJ, Hujer AM, Lowery KS, Sampath R, Bonomo RA | Culture Negative Empyema in A Critically Ill Child: An Opportunity for Rapid Molecular Diagnostics | 2014-11-22 | BMC Anesthesiol | BMC Anesthesiol. 2014 Nov 22;14:107. doi: 10.1186/1471-2253-14-107. eCollection 2014. |
| Perez F, Adachi J, Bonomo RA | Antibiotic-Resistant Gram-Negative Bacterial Infections in Patients with Cancer | 2014-11-15 | Clin Infect Dis | Clin Infect Dis. 2014 Nov 15;59 Suppl 5:S335-9. doi: 10.1093/cid/ciu612 |
| Stafford KA, Boutin M, Evans SR, Harris AD | Difficulties in Demonstrating Superiority of an Antibiotic for Multi-drug Resistant Bacteria in Non-Randomized Studies | 2014-10-15 | Clin Infect Dis | Clin Infect Dis. 2014 Oct 15;59(8):1142-7. doi: 10.1093/cid/ciu486. Epub 2014 Jun 30. |
| Perez F, Hujer AM, Marshall SH, Ray AJ, Rather PN, Suwantarant N, Dumford D III, OShea P, Domitrovic TNJ, Salata RA, Chavda KD, Chen L, Kreiswirth BN, Vila AJ, Haussler SH, Jacobs MR, Bonomo RA | Extensively Drug-Resistant Pseudomonas Aeruginosa Isolates Containing blaVIM-2 and Elements of Salmonella Genomic Island 2: A New Genetic Resistance Determinant in Northeast Ohio | 2014-10-01 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2014 Oct;58(10):5929-35. doi: 10.1128/AAC.02372-14. Epub 2014 Jul 28 |
| Spellberg B, Gibert DN | The Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett | 2014-09-15 | Clin Infect Dis | Clin Infect Dis. 2014 Sep 15;59 Suppl 2:S71-5. doi: 10.1093/cid/ciu392. |
| David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, Sieth J, Volinski J, Spellberg B | Staphylococcus aureus Bacteremia at Five U.S. Academic Medical Centers, 2008-2011: Significant Geographic Variation in Community-Onset Infections | 2014-09-15 | Clin Infect Dis | Clin Infect Dis. 2014 Sep 15;59(6):798-807. doi: 10.1093/cid/ciu410. Epub 2014 May 30. |
| Holland TL, Arnold C, Fowler VG Jr | Clinical Management of Staphylococcus aureus Bacteremia: A Review | 2014-09-01 | JAMA | JAMA. 2014 Oct 1;312(13):1330-41. doi: 10.1001/jama.2014.9743. |
| Nagalingam S, Lisgaris M, Rodriguez B, Jacobs MR, Lederman M, Salata RA, Hujer AM, Muehlenbachs A, DeLeon-Carnes M, Farrell JJ, Sampath R, Bonomo RA | Identification of Occult Fusobacterium Nucleatum Central Nervous System Infection By Use of PCR-Electrospray Ionization Mass Spectrometry | 2014-09-01 | J Clin Microbiol | J Clin Microbiol. 2014 Sep;52(9):3462-4. doi: 10.1128/JCM.01082-14. Epub 2014 Jun 25. |
| Wright MS, Perez F, Brinkac L, Jacobs MR, Kaye K, Cober E, van Duin D, Marshall SH, Hujer AM, Rudin SD, Hujer KM, Bonomo RA, Adams MD | Population Structure of KPC-producing Klebsiella pneumoniae from Midwestern US hospitals | 2014-08-01 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2014 Aug;58(8):4961-5. doi: 10.1128/AAC.00125-14. Epub 2014 Jun 9. |
| Asakura K, Hamasaki T, Sugimoto T, Hayashi K, Evans SR, Sozu T | Sample Size Determination in Group-Sequential Clinical Trials with Two Co-Primary Endpoints | 2014-07-01 | Stat Med | Stat Med. 2014 Jul 30;33(17):2897-913. doi: 10.1002/sim.6154. Epub 2014 Mar 27. |
| van Duin D, Perez F, Rudin SD, Cober E, Hanrahan J, Ziegler J, Webber R, Fox J, Mason P, Cline M, Hall G, Kaye K, Jacobs J, Kalayjian RC, Salata RA, Ramirez MS, Tolmalsky M, Evans S, Fowler VG Jr, Bonomo RA | Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network | 2014-07-01 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2014 Jul;58(7):4035-41. doi: 10.1128/AAC.02636-14. Epub 2014 May 5. |
| Spellberg B | The Future of Antibiotics | 2014-06-27 | Crit Care | Crit Care. 2014 Jun 27;18(3):228. doi: 10.1186/cc13948. |
| Ramirez MS, Xie G, Johnson S, Davenport K, van Duin D, Perez F, Bonomo RA, Chain P, Tolmasky ME | Genome Sequences of Two Carbapenemase-Resistant Klebsiella pneumoniae ST258 Isolates | 2014-06-19 | Genome Announc | Genome Announc. 2014 Jun 19;2(3). pii: e00558-14. doi: 10.1128/genomeA.00558-14. |
| Chambers HF, Bartlett JG, Bonomo RA, Chiou C, Cosgrove SE, Cross HR, Daum RS, Downing M, Evans SR, Knisely J, Kreiswirth BN, Lautenbach E, Mickley BS, Patel R, Pettigrew MM, Rodvold KA, Spellberg B, Fowler VG Jr. | Antibacterial Resistance Leadership Group: Open for Business | 2014-06-01 | Clin Infect Dis | Clin Infect Dis. 2014 Jun;58(11):1571-6. doi: 10.1093/cid/ciu132. Epub 2014 Mar 6. |
| Perez F, Bonomo RA | Vaccines for Acinetobacter baumannii: Thinking "Out of the Box" | 2014-05-07 | Vaccine | Vaccine. 2014 May 7;32(22):2537-9. |
| Fowler VG Jr, Proctor RA | Where Does a Staphylococcus Aureus Vaccine Stand | 2014-05-01 | Clin Microbiol Infect | Clin Microbiol Infect. 2014 May;20 Suppl 5:66-75. |
| Spellberg B | Antibiotic Judo: Working Gently with Prescriber Psychology to Overcome Inappropriate Use | 2014-03-31 | JAMA Intern Med | JAMA Intern Med. 2014 Mar;174(3):432-3. doi: 10.1001/jamainternmed.2013.14019. |
| Perez F, Rudin SD, Marshall SH, Coakley P, Chen L, Kreiswirth BN, Rather PN, Hujer AM, Toltzis P, van Duin D, Paterson DL, Bonomo RA | OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin | 2013-09-01 | Antimicrob Agents Chemother | Antimicrob Agents Chemother. 2013 Sep;57(9):4602-3. |
ARLG addresses antibacterial resistance through innovative clinical trial design, unique access to clinically well-characterized bacteria, and opportunities for early-stage investigators.
Let's Collaborate